Cyberonics Q1 Epilepsy Sales Up 16%; Firm Continues To Ramp Up R&D Spend
Epilepsy devicemaker Cyberonics reported 19% growth in U.S. epilepsy sales to $30.7 million for the first quarter of 2010 (ended July 24)
Epilepsy devicemaker Cyberonics reported 19% growth in U.S. epilepsy sales to $30.7 million for the first quarter of 2010 (ended July 24)